Natural History Studies For Rare Diseases: Development Strategies For External Comparator Arms Leveraging Real World Insights
Source: IQVIA Biotech
By Emily Bratton, PHD, MSPH,Cassie Holt, PHD, MPH, CPH, Sarah Kromrey, PHD, Jeffrey Keefer, MD, PHD
This paper explores essential principles for defining the right strategy for natural history studies and how to design such studies in a way that the data can be used as an external comparator to augment future regulatory filings and payer submissions. For more information, download the available white paper.
access the White Paper!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
IQVIA Biotech
This website uses cookies to ensure you get the best experience on our website. Learn more